Table 6.

Comparison of SCT procedures performed in first CR in patients who had de novo AML, were 60 years old or younger and had normal karyotype (N = 154)

NPM1-mut/FLT3-ITDneg
NPM1-mut/FLT3-ITDpos
NPM1-wt/FLT3-ITDpos
NPM1-wt/FLT3-ITDneg
No.   44   28   25   57  
Autologous, no.   29   18   13   25  
Allogeneic, family, no.   15   8   10   27  
Allogeneic, unrelated, no.
 		 0
 		 2
 		 2
 		 5
 
NPM1-mut/FLT3-ITDneg
NPM1-mut/FLT3-ITDpos
NPM1-wt/FLT3-ITDpos
NPM1-wt/FLT3-ITDneg
No.   44   28   25   57  
Autologous, no.   29   18   13   25  
Allogeneic, family, no.   15   8   10   27  
Allogeneic, unrelated, no.
 		 0
 		 2
 		 2
 		 5
 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal